Loading…

PPARα activation is essential for HCV core protein–induced hepatic steatosis and hepatocellular carcinoma in mice

Transgenic mice expressing HCV core protein develop hepatic steatosis and hepatocellular carcinoma (HCC), but the mechanism underlying this process remains unclear. Because PPARα is a central regulator of triglyceride homeostasis and mediates hepatocarcinogenesis in rodents, we determined whether PP...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of clinical investigation 2008-02, Vol.118 (2), p.683-694
Main Authors: Tanaka, Naoki, Moriya, Kyoji, Kiyosawa, Kendo, Koike, Kazuhiko, Gonzalez, Frank J, Aoyama, Toshifumi
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c565t-f62d13733545c8c8534c39f8de37c2bb1d12597a72c62f4bf75a7c9cb8bb40d53
cites
container_end_page 694
container_issue 2
container_start_page 683
container_title The Journal of clinical investigation
container_volume 118
creator Tanaka, Naoki
Moriya, Kyoji
Kiyosawa, Kendo
Koike, Kazuhiko
Gonzalez, Frank J
Aoyama, Toshifumi
description Transgenic mice expressing HCV core protein develop hepatic steatosis and hepatocellular carcinoma (HCC), but the mechanism underlying this process remains unclear. Because PPARα is a central regulator of triglyceride homeostasis and mediates hepatocarcinogenesis in rodents, we determined whether PPARα contributes to HCV core protein--induced diseases. We generated PPARα-homozygous, -heterozygous, and -null mice with liver-specific transgenic expression of the core protein gene (Ppara+/+:HCVcpTg, Ppara+/-:HCVcpTg, and Ppara-/-:HCVcpTg mice. Severe steatosis was unexpectedly observed only in Ppara+/+:HCVcpTg mice, which resulted from enhanced fatty acid uptake and decreased mitochondrial β-oxidation due to breakdown of mitochondrial outer membranes. Interestingly, HCC developed in approximately 35% of 24-month-old Ppara+/+: HCVcpTg mice, but tumors were not observed in the other genotypes. These phenomena were found to be closely associated with sustained PPARα activation. In Ppara+/-:HCVcpTg mice, PPARα activation and the related changes did not occur despite the presence of a functional Ppara allele. However, long-term treatment of these mice with clofibrate, a PPARα activator, induced HCC with mitochondrial abnormalities and hepatic steatosis. Thus, our results indicate that persistent activation of PPARα is essential for the pathogenesis of hepatic steatosis and HCC induced by HCV infection.
doi_str_mv 10.1172/JCI33594
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2176192</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A174617163</galeid><sourcerecordid>A174617163</sourcerecordid><originalsourceid>FETCH-LOGICAL-c565t-f62d13733545c8c8534c39f8de37c2bb1d12597a72c62f4bf75a7c9cb8bb40d53</originalsourceid><addsrcrecordid>eNqNkk1uFDEQhXsBIiEgcQSvECw6tP_a3Ruk0QjIoEiJAmRruaurZ4w89sh2R7DjDpyEi3AIToKjCYiRskC1KKn8vSe9clXVM9qcUqrYq_fLFeeyFw-q46ZhtO4V746qxyl9bhoqhBSPqiPa0a4Toj-u8uXl4urnD2Ig2xuTbfDEJoIpoc_WODKFSM6W1wRCRLKLIaP1v759t36cAUeywV0RAUkZTQ6pSI2_mwZA52ZnIgETwfqwNcR6srWAT6qHk3EJn971k-rT2zcfl2f1-cW71XJxXoNsZa6nlo2Uq5JGSOigk1wA76duRK6ADQMdKZO9MopByyYxTEoaBT0M3TCIZpT8pHq9993NwxZHKJmicXoX7dbErzoYqw9fvN3odbjRjKqW9qwY1HuDtXGorZ9CwWCNHgsdPE62jBdUiZYq2vLCn97Dlxqx5L5X8PJAUJiMX_LazCnp1Yer_2cvrg_Z5_-wGzQub1Jw8-0Hp0PwxR6EGFKKOP3dDm307T3pP_fEfwPVIL6g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>PPARα activation is essential for HCV core protein–induced hepatic steatosis and hepatocellular carcinoma in mice</title><source>PubMed (Medline)</source><source>EZB Electronic Journals Library</source><creator>Tanaka, Naoki ; Moriya, Kyoji ; Kiyosawa, Kendo ; Koike, Kazuhiko ; Gonzalez, Frank J ; Aoyama, Toshifumi</creator><creatorcontrib>Tanaka, Naoki ; Moriya, Kyoji ; Kiyosawa, Kendo ; Koike, Kazuhiko ; Gonzalez, Frank J ; Aoyama, Toshifumi</creatorcontrib><description>Transgenic mice expressing HCV core protein develop hepatic steatosis and hepatocellular carcinoma (HCC), but the mechanism underlying this process remains unclear. Because PPARα is a central regulator of triglyceride homeostasis and mediates hepatocarcinogenesis in rodents, we determined whether PPARα contributes to HCV core protein--induced diseases. We generated PPARα-homozygous, -heterozygous, and -null mice with liver-specific transgenic expression of the core protein gene (Ppara+/+:HCVcpTg, Ppara+/-:HCVcpTg, and Ppara-/-:HCVcpTg mice. Severe steatosis was unexpectedly observed only in Ppara+/+:HCVcpTg mice, which resulted from enhanced fatty acid uptake and decreased mitochondrial β-oxidation due to breakdown of mitochondrial outer membranes. Interestingly, HCC developed in approximately 35% of 24-month-old Ppara+/+: HCVcpTg mice, but tumors were not observed in the other genotypes. These phenomena were found to be closely associated with sustained PPARα activation. In Ppara+/-:HCVcpTg mice, PPARα activation and the related changes did not occur despite the presence of a functional Ppara allele. However, long-term treatment of these mice with clofibrate, a PPARα activator, induced HCC with mitochondrial abnormalities and hepatic steatosis. Thus, our results indicate that persistent activation of PPARα is essential for the pathogenesis of hepatic steatosis and HCC induced by HCV infection.</description><identifier>ISSN: 0021-9738</identifier><identifier>DOI: 10.1172/JCI33594</identifier><identifier>PMID: 18188449</identifier><language>eng</language><publisher>American Society for Clinical Investigation</publisher><subject>Health aspects ; Hepatitis C ; Hepatitis C virus ; Hepatoma ; Risk factors</subject><ispartof>The Journal of clinical investigation, 2008-02, Vol.118 (2), p.683-694</ispartof><rights>COPYRIGHT 2008 American Society for Clinical Investigation</rights><rights>Copyright © 2008, American Society for Clinical Investigation 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c565t-f62d13733545c8c8534c39f8de37c2bb1d12597a72c62f4bf75a7c9cb8bb40d53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2176192/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2176192/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Tanaka, Naoki</creatorcontrib><creatorcontrib>Moriya, Kyoji</creatorcontrib><creatorcontrib>Kiyosawa, Kendo</creatorcontrib><creatorcontrib>Koike, Kazuhiko</creatorcontrib><creatorcontrib>Gonzalez, Frank J</creatorcontrib><creatorcontrib>Aoyama, Toshifumi</creatorcontrib><title>PPARα activation is essential for HCV core protein–induced hepatic steatosis and hepatocellular carcinoma in mice</title><title>The Journal of clinical investigation</title><description>Transgenic mice expressing HCV core protein develop hepatic steatosis and hepatocellular carcinoma (HCC), but the mechanism underlying this process remains unclear. Because PPARα is a central regulator of triglyceride homeostasis and mediates hepatocarcinogenesis in rodents, we determined whether PPARα contributes to HCV core protein--induced diseases. We generated PPARα-homozygous, -heterozygous, and -null mice with liver-specific transgenic expression of the core protein gene (Ppara+/+:HCVcpTg, Ppara+/-:HCVcpTg, and Ppara-/-:HCVcpTg mice. Severe steatosis was unexpectedly observed only in Ppara+/+:HCVcpTg mice, which resulted from enhanced fatty acid uptake and decreased mitochondrial β-oxidation due to breakdown of mitochondrial outer membranes. Interestingly, HCC developed in approximately 35% of 24-month-old Ppara+/+: HCVcpTg mice, but tumors were not observed in the other genotypes. These phenomena were found to be closely associated with sustained PPARα activation. In Ppara+/-:HCVcpTg mice, PPARα activation and the related changes did not occur despite the presence of a functional Ppara allele. However, long-term treatment of these mice with clofibrate, a PPARα activator, induced HCC with mitochondrial abnormalities and hepatic steatosis. Thus, our results indicate that persistent activation of PPARα is essential for the pathogenesis of hepatic steatosis and HCC induced by HCV infection.</description><subject>Health aspects</subject><subject>Hepatitis C</subject><subject>Hepatitis C virus</subject><subject>Hepatoma</subject><subject>Risk factors</subject><issn>0021-9738</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqNkk1uFDEQhXsBIiEgcQSvECw6tP_a3Ruk0QjIoEiJAmRruaurZ4w89sh2R7DjDpyEi3AIToKjCYiRskC1KKn8vSe9clXVM9qcUqrYq_fLFeeyFw-q46ZhtO4V746qxyl9bhoqhBSPqiPa0a4Toj-u8uXl4urnD2Ig2xuTbfDEJoIpoc_WODKFSM6W1wRCRLKLIaP1v759t36cAUeywV0RAUkZTQ6pSI2_mwZA52ZnIgETwfqwNcR6srWAT6qHk3EJn971k-rT2zcfl2f1-cW71XJxXoNsZa6nlo2Uq5JGSOigk1wA76duRK6ADQMdKZO9MopByyYxTEoaBT0M3TCIZpT8pHq9993NwxZHKJmicXoX7dbErzoYqw9fvN3odbjRjKqW9qwY1HuDtXGorZ9CwWCNHgsdPE62jBdUiZYq2vLCn97Dlxqx5L5X8PJAUJiMX_LazCnp1Yer_2cvrg_Z5_-wGzQub1Jw8-0Hp0PwxR6EGFKKOP3dDm307T3pP_fEfwPVIL6g</recordid><startdate>20080201</startdate><enddate>20080201</enddate><creator>Tanaka, Naoki</creator><creator>Moriya, Kyoji</creator><creator>Kiyosawa, Kendo</creator><creator>Koike, Kazuhiko</creator><creator>Gonzalez, Frank J</creator><creator>Aoyama, Toshifumi</creator><general>American Society for Clinical Investigation</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>5PM</scope></search><sort><creationdate>20080201</creationdate><title>PPARα activation is essential for HCV core protein–induced hepatic steatosis and hepatocellular carcinoma in mice</title><author>Tanaka, Naoki ; Moriya, Kyoji ; Kiyosawa, Kendo ; Koike, Kazuhiko ; Gonzalez, Frank J ; Aoyama, Toshifumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c565t-f62d13733545c8c8534c39f8de37c2bb1d12597a72c62f4bf75a7c9cb8bb40d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Health aspects</topic><topic>Hepatitis C</topic><topic>Hepatitis C virus</topic><topic>Hepatoma</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tanaka, Naoki</creatorcontrib><creatorcontrib>Moriya, Kyoji</creatorcontrib><creatorcontrib>Kiyosawa, Kendo</creatorcontrib><creatorcontrib>Koike, Kazuhiko</creatorcontrib><creatorcontrib>Gonzalez, Frank J</creatorcontrib><creatorcontrib>Aoyama, Toshifumi</creatorcontrib><collection>CrossRef</collection><collection>Gale in Context : Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tanaka, Naoki</au><au>Moriya, Kyoji</au><au>Kiyosawa, Kendo</au><au>Koike, Kazuhiko</au><au>Gonzalez, Frank J</au><au>Aoyama, Toshifumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PPARα activation is essential for HCV core protein–induced hepatic steatosis and hepatocellular carcinoma in mice</atitle><jtitle>The Journal of clinical investigation</jtitle><date>2008-02-01</date><risdate>2008</risdate><volume>118</volume><issue>2</issue><spage>683</spage><epage>694</epage><pages>683-694</pages><issn>0021-9738</issn><abstract>Transgenic mice expressing HCV core protein develop hepatic steatosis and hepatocellular carcinoma (HCC), but the mechanism underlying this process remains unclear. Because PPARα is a central regulator of triglyceride homeostasis and mediates hepatocarcinogenesis in rodents, we determined whether PPARα contributes to HCV core protein--induced diseases. We generated PPARα-homozygous, -heterozygous, and -null mice with liver-specific transgenic expression of the core protein gene (Ppara+/+:HCVcpTg, Ppara+/-:HCVcpTg, and Ppara-/-:HCVcpTg mice. Severe steatosis was unexpectedly observed only in Ppara+/+:HCVcpTg mice, which resulted from enhanced fatty acid uptake and decreased mitochondrial β-oxidation due to breakdown of mitochondrial outer membranes. Interestingly, HCC developed in approximately 35% of 24-month-old Ppara+/+: HCVcpTg mice, but tumors were not observed in the other genotypes. These phenomena were found to be closely associated with sustained PPARα activation. In Ppara+/-:HCVcpTg mice, PPARα activation and the related changes did not occur despite the presence of a functional Ppara allele. However, long-term treatment of these mice with clofibrate, a PPARα activator, induced HCC with mitochondrial abnormalities and hepatic steatosis. Thus, our results indicate that persistent activation of PPARα is essential for the pathogenesis of hepatic steatosis and HCC induced by HCV infection.</abstract><pub>American Society for Clinical Investigation</pub><pmid>18188449</pmid><doi>10.1172/JCI33594</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9738
ispartof The Journal of clinical investigation, 2008-02, Vol.118 (2), p.683-694
issn 0021-9738
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2176192
source PubMed (Medline); EZB Electronic Journals Library
subjects Health aspects
Hepatitis C
Hepatitis C virus
Hepatoma
Risk factors
title PPARα activation is essential for HCV core protein–induced hepatic steatosis and hepatocellular carcinoma in mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A11%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PPAR%CE%B1%20activation%20is%20essential%20for%20HCV%20core%20protein%E2%80%93induced%20hepatic%20steatosis%20and%20hepatocellular%20carcinoma%20in%20mice&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Tanaka,%20Naoki&rft.date=2008-02-01&rft.volume=118&rft.issue=2&rft.spage=683&rft.epage=694&rft.pages=683-694&rft.issn=0021-9738&rft_id=info:doi/10.1172/JCI33594&rft_dat=%3Cgale_pubme%3EA174617163%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c565t-f62d13733545c8c8534c39f8de37c2bb1d12597a72c62f4bf75a7c9cb8bb40d53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/18188449&rft_galeid=A174617163&rfr_iscdi=true